Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up

17 April 2023 (15:40 - 16:40)
Organised by:
Congress Presentation Part of: Device Therapy - ICD Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2023

ESC 365 is supported by

ESC 365 is supported by